The estimated Net Worth of Brian Lian is at least $173 million dollars as of 21 August 2024. Brian Lian owns over 1,000 units of Viking Therapeutics Inc stock worth over $143,311,039 and over the last 10 years he sold VKTX stock worth over $25,853,736. In addition, he makes $3,512,120 as President, Chief Executive Officer et Director at Viking Therapeutics Inc.
Sign up
Brian Lian VKTX stock SEC Form 4 insiders trading
Brian has made over 12 trades of the Viking Therapeutics Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently he exercised 1,000 units of VKTX stock worth $7,770 on 21 August 2024.
The largest trade he's ever made was selling 269,079 units of Viking Therapeutics Inc stock on 8 February 2024 worth over $7,230,153. On average, Brian trades about 31,320 units every 13 days since 2015. As of 21 August 2024 he still owns at least 2,355,927 units of Viking Therapeutics Inc stock.
You can see the complete history of Brian Lian stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Brian Lian biography
Dr. Brian W. Lian Ph.D. serves as President, Chief Executive Officer, Director of the Company. He has served as our President and Chief Executive Officer and as a Director since our inception in September 2012. Dr. Lian has over 15 years of experience in the biotechnology and financial services industries. Prior to joining Viking, he was a Managing Director and Senior Research Analyst at SunTrust Robinson Humphrey, an investment bank, from 2012 to 2013. At SunTrust Robinson Humphrey, he was responsible for coverage of small and mid-cap biotechnology companies with an emphasis on companies in the diabetes, oncology, infectious disease and neurology spaces. Prior to SunTrust Robinson Humphrey, he was Managing Director and Senior Research Analyst at Global Hunter Securities, an investment bank, from 2011 to 2012. Prior to Global Hunter Securities, he was Senior Healthcare Analyst at The Agave Group, LLC, a registered investment advisor, from 2008 to 2011. Prior to The Agave Group, he was an Executive Director and Senior Biotechnology Analyst at CIBC World Markets, an investment bank, from 2006 to 2008. Prior to CIBC, he was a research scientist in small molecule drug discovery at Amgen, a biotechnology company. Prior to Amgen, he was a research scientist at Microcide Pharmaceuticals, a biotechnology company. Dr. Lian has served as a member of the board of directors of Seelos Therapeutics, Inc. since January 2019. Dr. Lian holds an MBA in accounting and finance from Indiana University, an MS and Ph.D. in organic chemistry from The University of Michigan, and a BA in chemistry from Whitman College.
What is the salary of Brian Lian?
As the President, Chief Executive Officer et Director of Viking Therapeutics Inc, the total compensation of Brian Lian at Viking Therapeutics Inc is $3,512,120. There are no executives at Viking Therapeutics Inc getting paid more.
How old is Brian Lian?
Brian Lian is 54, he's been the President, Chief Executive Officer et Director of Viking Therapeutics Inc since 2015. There are 7 older and 2 younger executives at Viking Therapeutics Inc. The oldest executive at Viking Therapeutics Inc is J. Matthew Singleton, 67, who is the Independent Director.
What's Brian Lian's mailing address?
Brian's mailing address filed with the SEC is C/O VIKING THERAPEUTICS, INC., 9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA, 92121.
Insiders trading at Viking Therapeutics Inc
Over the last 10 years, insiders at Viking Therapeutics Inc have traded over $46,107,976 worth of Viking Therapeutics Inc stock and bought 199,715 units worth $855,627 . The most active insiders traders include Brian Lian, Charles A Jr Rowland et Marianna Mancini. On average, Viking Therapeutics Inc executives and independent directors trade stock every 75 days with the average trade being worth of $4,137,170. The most recent stock trade was executed by Brian Lian on 21 August 2024, trading 1,000 units of VKTX stock currently worth $7,770.
What does Viking Therapeutics Inc's logo look like?
Complete history of Brian Lian stock trades at Viking Therapeutics Inc et Seelos Therapeutics
Viking Therapeutics Inc executives and stock owners
Viking Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Brian Lian,
President, Chief Executive Officer, Director -
Dr. Brian Lian Ph.D.,
Pres, CEO & Director -
Michael Morneau,
Vice President - Finance and Administration -
S. Kathy Rouan,
Independent Director -
Lawson Macartney,
Independent Chairman of the Board -
Charles Rowland,
Independent Director -
J. Matthew Singleton,
Independent Director -
Matthew Foehr,
Director -
Greg Zante,
Senior Vice President - Finance, IR Contact Officer -
Michael Morneau,
VP of Fin. & Admin. -
Marianne Mancini,
Chief Operating Officer -
Gregory S. Zante,
Chief Financial Officer -
Pharmaceuticals Inc Ligand,
10% owner -
Stephen W Webster,
Director -
Rochelle Hanley,
Chief Medical Officer -
Hiroko Masamune,
Chief Development Officer -
Marianna Mancini,
Chief Operating Officer -
Michael Dinerman,
Chief Operating Officer